Identifying NSCLC patients who 1 benefit from afatinib therapy using [F-18]afatinib PET/CT

Van de Stadt, E; Bahce, I; Yaqub, M; Poot, A; Smit, E; Hendrikse, H

JOURNAL OF NUCLEAR MEDICINE, 2019; 60 ():